Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory rheumatic disease characterized by pain, stiffness, swollen joints, joint erosion, and bone formation. Clinical manifestations vary greatly between patients. It can present with oligoarticular joint involvement that is typically asymmetric or as a polyarticular disease affecting five or more joints, usually with an asymmetric distribution similar to that of rheumatoid arthritis.
The current practice relies on the individualizing choice of treatment by matching the most severely affected domains of the patients with the best available evidence of efficacies of drugs for those domains. When patients do not respond to treatment, shifting and cycling through different options would be the rational steps.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market
The Psoriatic Arthritis market report also covers emerging drugs, current treatment practices, Psoriatic Arthritis market share of the individual therapies, current and forecasted Psoriatic Arthritis Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Psoriatic Arthritis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Psoriatic Arthritis Market Key Facts
-
According to a study by Pérez et., al (2020), the prevalence of PsA in Spain was among the highest reported to date, only below that reported in Norway (0.67%) and slightly higher than that reported in Italy (0.42%).
-
According to the National Psoriatic Foundation, about 1 in 3 people or 30% with psoriasis develop psoriatic arthritis (PsA) – as many as 2.4 million Americans – and PsA can develop at any age.
-
According to a retrospective study of German healthcare insurance data, PsA had prevalence rates of 0.3% respectively, in 2016 (Grellmann et al., 2020)
-
As per the estimates by DelveInsight, there is no gender-based difference but the prevalence of severe cases is the highest followed by moderate and mild.
Key Benefits of Psoriatic Arthritis Market Report
-
Psoriatic Arthritis market report provides an in-depth analysis of Psoriatic Arthritis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
-
The Psoriatic Arthritis market report will help in developing business strategies by understanding the Psoriatic Arthritis Market trends & developments, key players, and future market competition that will shape and drive the Psoriatic Arthritis market in the upcoming years.
-
The Psoriatic Arthritis market report covers Psoriatic Arthritis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Psoriatic Arthritis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Psoriatic Arthritis market size is expected to increase during the forecast period owing to the launch of Biosimilars and Biologics as well as the rise in prevalence and expedite R&D.
The Psoriatic Arthritis market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Psoriatic Arthritis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Psoriatic Arthritis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Psoriatic Arthritis Epidemiology
The Psoriatic Arthritis epidemiology section covers insights about the historical and current Psoriatic Arthritis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Psoriatic Arthritis Drugs Uptake and Key Market Players
The Psoriatic Arthritis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriatic Arthritis market or expected to get launched in the market during the study period. The analysis covers Psoriatic Arthritis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Psoriatic Arthritis companies:
Pfizer
AbbVie
Sun Pharma
UCB Biopharma
Bristol-Myers Squibb
And many others.
Psoriatic Arthritis therapies covered in the report include:
Skyrizi
Ilumya (tildrakizumab-asmn)
Deucravacitinib
Rinvoq
Bimekizumab
Brepocitinib
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Psoriatic Arthritis Competitive Intelligence Analysis
4. Psoriatic Arthritis Market Overview at a Glance
5. Psoriatic Arthritis Disease Background and Overview
6. Psoriatic Arthritis Patient Journey
7. Psoriatic Arthritis Epidemiology and Patient Population
8. Psoriatic Arthritis Treatment Algorithm, Current Treatment, and Medical Practices
9. Psoriatic Arthritis Unmet Needs
10. Key Endpoints of Psoriatic Arthritis Treatment
11. Psoriatic Arthritis Marketed Products
12. Psoriatic Arthritis Emerging Therapies
13. Psoriatic Arthritis Seven Major Market Analysis
14. Attribute Analysis
15. Psoriatic Arthritis Market Outlook (7 major markets)
16. Psoriatic Arthritis Access and Reimbursement Overview
17. KOL Views on the Psoriatic Arthritis Market.
18. Psoriatic Arthritis Market Drivers
19. Psoriatic Arthritis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Related Reports
Psoriatic Arthritis Epidemiology Forecast
DelveInsight’s Psoriatic Arthritis – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Psoriatic Arthritis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Psoriatic Arthritis Pipeline Insights
Psoriatic Arthritis Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Psoriatic Arthritis market.
Recent BioPharma Blog – Hemophagocytic Lymphohistiocytosis (HLH) Therapeutics Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/